| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |